Search Results - "Ademi, Z."

Refine Results
  1. 1

    A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting by Matter-Walstra, K., Braun, R., Kolb, C., Ademi, Z., Dummer, R., Pestalozzi, B.C., Schwenkglenks, M.

    Published in British journal of dermatology (1951) (01-12-2015)
    “…Summary Background The treatment of patients with metastatic melanomas that harbour BRAF V600E or V600K mutations with trametinib plus dabrafenib appears to be…”
    Get full text
    Journal Article
  2. 2

    4B.04: COST-UTILITY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR COMPARED TO THIAZIDE DIURETIC -BASED TREATMENT FOR HYPERTENSION IN ELDERLY AUSTRALIANS CONSIDERING DIABETES AS COMORBIDITY by Chowdhury, E, Ademi, Z, Moss, J, Wing, L, Reid, C

    Published in Journal of hypertension (01-06-2015)
    “…OBJECTIVE:To examine the cost-effectiveness of angiotensin-converting enzyme inhibitor-based (ACEI) treatment compared to thiazide diuretic-based treatment for…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Economic implications of obesity among people with atherothrombotic disease by Ademi Z, Walls, H.L, Peeters, A, Liew, D, Hollingsworth, B, Stevenson, C, Steg, Ph-G, Bhatt, D.L, Reid, C.M

    Published in International Journal of Obesity (01-08-2010)
    “…Objective: The purpose of this study was to ascertain the impact of obesity on the cost of disease management in people with or at high risk of…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20